Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
5.90
+0.14 (2.43%)
Sep 30, 2026, 2:56 PM EDT - Market open
Cytek Biosciences Market Cap
Cytek Biosciences has a market cap or net worth of $766.9 million as of September 30, 2026. Its market cap has increased by 78.34% in one year.
Market Cap
766.90M
Enterprise Value
531.36M
1-Year Change
78.34%
Ranking
Category
Stock Price
$5.90
ChartMarket Cap Chart
Since the IPO on July 23, 2021, Cytek Biosciences's market cap has decreased from $2.26B to $766.90M, a decrease of -66.08%. That is a compound annual growth rate of -18.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 766.90M | 18.77% |
| Dec 31, 2025 | 645.72M | -22.76% |
| Dec 31, 2024 | 835.98M | -32.38% |
| Dec 29, 2023 | 1.24B | -10.21% |
| Dec 30, 2022 | 1.38B | -36.91% |
| Dec 31, 2021 | 2.18B | -3.47% |
| Jul 23, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lumexa Imaging Holdings | 985.73M |
| CeriBell | 954.08M |
| SI-BONE | 858.28M |
| InMode | 817.38M |
| Varex Imaging | 778.47M |
| AdaptHealth | 756.43M |
| Anteris Technologies Global | 739.71M |
| QuidelOrtho | 726.56M |